2.07
+0.015(+0.73%)
Currency In USD
| Previous Close | 2.05 |
| Open | 2.09 |
| Day High | 2.09 |
| Day Low | 2.07 |
| 52-Week High | 5.22 |
| 52-Week Low | 1 |
| Volume | 5,927 |
| Average Volume | 73,626 |
| Market Cap | 49.46M |
| PE | -0.78 |
| EPS | -2.64 |
| Moving Average 50 Days | 1.89 |
| Moving Average 200 Days | 2.09 |
| Change | 0.02 |
If you invested $1000 in Celularity Inc. (CELU) since IPO date, it would be worth $21.07 as of July 02, 2025 at a share price of $2.065. Whereas If you bought $1000 worth of Celularity Inc. (CELU) shares 5 years ago, it would be worth $20.49 as of July 02, 2025 at a share price of $2.065.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies
GlobeNewswire Inc.
Yesterday at 12:30 PM GMT
New law goes into effect on July 1st authorizing Florida physicians to provide stem cell therapies to their patients for orthopedics, wound care, and pain management FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CE
Celularity Announces Chief Financial Officer Transition
GlobeNewswire Inc.
Jun 10, 2025 8:15 PM GMT
Celularity retains financial and business advisor to provide outsourced accounting and consulting services during the transition periodFLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Compan
Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology
GlobeNewswire Inc.
Jun 02, 2025 12:00 PM GMT
Highlights the unique potential of Celularity’s proprietary advanced biomaterial technology as a novel cellular delivery system for ocular surface reconstructionSupports broad range of regenerative medicine applications beyond ophthalmology FLORHAM P